Uzbekistan Childhood Cancer Care: Early Diagnosis and Survival Rates Rise

More than 2,500 children in Uzbekistan are diagnosed with a malignant tumour or haemoblastosis each year for the first time, according to Podrobno.uz. Late diagnosis, access to medicines and the need to travel to Tashkent for treatment remain serious challenges. Authorities intend to change the treatment system by 2030, focusing on early detection, regional infrastructure and higher survival.

According to the National Register, 2,416 new cases of malignant neoplasms and haemoblastoses were registered in 2024 and 2,534 in 2025. Data from the centre show that more than 70% of children with solid malignant tumours presented at stages III–IV. Early detection of solid malignant tumours rose from 23% in 2023 to 28% in 2025. One-year survival for malignant oncological diseases increased from 37% to 44.5%, and for haemoblastoses from 17% to 42%.

The national strategy aims to raise early detection to 65% and achieve five-year survival of at least 60% by 2030. In high-income countries, five-year survival for children with cancer exceeds 80%. Regional multidisciplinary children's hospitals have paediatric oncology and haematology departments, and the Samarkand complex is preparing to open.